Home › Funds › UBS Group AG › INTS
UBS Group AG position in INTS
INTENSITY THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1 sh
Reported value held$4
Portfolio Weight0.00%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 500 | $4.29K | New |
| Q1 2024 | 3.01K | $15.66K | Add |
| Q2 2024 | 3.32K | $16.25K | Add |
| Q3 2024 | 20.61K | $78.73K | Add |
| Q4 2024 | 3.02K | $5.32K | Reduce |
| Q1 2025 | 3.10K | $6.10K | Add |
| Q2 2025 | 9.23K | $2.83K | Add |
| Q3 2025 | 136.23K | $33.10K | Add |
| Q4 2025 | 25.40K | $10.41K | Reduce |
| Q1 2026 | 192 | $1.13K | Reduce |
| Q2 2026 | 1 | $4 | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding INTS
- Vanguard Group 649.08K sh · $266.12K · Q4 2025
- Geode Capital Management 22.79K sh · $93.43K · Q2 2026
- Morgan Stanley 20 sh · $82 · Q2 2026